Cyclacel Pharmaceuticals announces 15-1 reverse stock split
Cyclacel Pharmaceuticals (CYCC) announced that they are hoping to implement a one-to-15 reverse. Stock split There will be transactions for common stock on July 7, 2025, which commence on a split basis in the market opened that day. Common stock trading continues in the capital markets of NASDAQ under the symbol “CYCC.” The new CUSIP number for common stock after the reverse stock split is 23254L876.
Don’t miss out on Tipranks’ six-month sales
First published fly – The ultimate source of financial news that moves to the market in real time. Try it now >>
See insider hot stocks on Tipranks >>
Read more about CYCC: